John contributes significant experience of leadership at a senior level within the vaccine industry.Find out more
The ImmBio Board of Directors comprises of an independent Chairman, two Directors drawn from investors, two independent Directors and the company’s CEO.
David is responsible for Portfolio management across YFM Equity Partners and direct management of a number of investments.Find out more
Ashok brings more than 20 years of healthcare experience, focused on Corporate Development, Mergers & Acquisitions and Strategic Planning.Find out more
Graham Clarke has extensive experience of the pharmaceutical industry in a number of senior commercial roles and, as CEO of ImmBio till 2017, established its development portfolio and secured investment, grants and licenses.Find out more
Bill is an NXC/NXD of a portfolio of healthcare and life science businesses, private and public, with experience of IPOs and VC fundingFind out more